Biogen (BIIB) Invested Capital (2009 - 2026)

Biogen has reported Invested Capital for 18 years, with the latest figure at $26.9 billion in Q2 2026.

• On a quarterly basis, Invested Capital rose 11.93% year-over-year to $26.9 billion in Q2 2026; TTM through Jun 2026 was $26.9 billion, a 11.93% increase from a year earlier, with the FY2025 full-year figure at $24.5 billion, down 0.88% from the prior year.
• Invested Capital was $26.9 billion for Q2 2026 at Biogen, up from $24.9 billion in the prior quarter.
• The five-year high for Invested Capital was $26.9 billion in Q2 2026, with the low at $19.0 billion in Q3 2022.
• Average Invested Capital over 5 years is $22.6 billion, with a median of $22.1 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Invested Capital increased 14.28% in 2023, then declined 0.88% in 2025.
• Over 5 years, Invested Capital stood at $19.7 billion in 2022, then gained by 11.28% to $21.9 billion in 2023, then advanced by 13.13% to $24.8 billion in 2024, then slipped by 0.88% to $24.5 billion in 2025, then climbed by 9.76% to $26.9 billion in 2026.
• The last three Invested Capital figures came in at $26.9 billion (Q2 2026), $24.9 billion (Q1 2026), and $24.5 billion (Q4 2025), per Business Quant data.